Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...
Researchers have invented a smartphone-controlled soft-brain implant that can be recharged wirelessly from outside the b...
Melbourne-based biotech Starpharma has launched its antiviral nasal spray VIRALEZE™ into the UK via a large nation...
China based Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and...
Image Caption: Fluorescence staining of the epithelial markers of the NPC organoids Singapore, A*STAR’s Inst...
Bright Peak Therapeutics Inc., a biotechnology company developing next-generation immunotherapies for cancer and autoimm...
Scientists at the Pohang University of Science and Technology (POSTECH) in South Korea have succeeded in producing ...
Image Caption: Experiment setup with Dr Kerwin Kwek for the profiling of immune cells using the microfluidic DLD assay...
Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, ...
An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown Un...
The Australian government is providing $2.6 million to researchers at the University of Melbourne to use the latest info...
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although...
A first-in-class cancer drug delivery system developed by Taiwan's National Health Research Institutes (NHRI) has receiv...
Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative diseases, such as C9ORF72-associated...
The Australian government is launching a $15 million competitive grant round to kick start Australian clinical trials ex...
ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset ...
Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...
Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as th...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to ...
The Australian Government is investing $100 million into the development of new technologies to improve diagnosis and tr...
Genome & Company, a global leading immuno-oncology firm based in South Korea, and Debiopharm, a Swiss-based biopharm...
Illumina, Inc. on Feb 19, 2021 announced an agreement with the Institute of Medical Genetics and Applied Genomics at the...
Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its PS128 psychob...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in the gradual loss of motor nerve cells (n...
